Literature DB >> 19553527

IL-17 and IFN-gamma mediate the elicitation of contact hypersensitivity responses by different mechanisms and both are required for optimal responses.

Donggou He1, Lizhi Wu, Hee Kyung Kim, Hui Li, Craig A Elmets, Hui Xu.   

Abstract

Hapten-induced contact hypersensitivity (CHS) in the skin is a delayed type cellular immune response that can be mediated by CD8(+) T cells that produce IFN-gamma or IL-17. However, mechanisms for these cytokines in the elicitation of CHS remain to be fully elucidated. In this study, we show that adoptive transfer of CHS with hapten-primed wild-type (WT) CD8(+) T cells is reduced in IFN-gammaR(-/-) or IL-17R(-/-) mice compared with WT controls. The infiltration of granulocytes and macrophages in the hapten challenged skin of IL-17R(-/-) recipients is significantly reduced whereas it is less affected in IFN-gammaR(-/-) recipients although CD8(+) T cell infiltration is inhibited in both recipients. In contrast, the activity of reactive oxidative species is significantly inhibited in IFN-gammaR(-/-) but is less affected in IL-17R(-/-) recipients. Further analysis reveals that the expression of chemokines and cytokines is differentially regulated in the hapten-challenged skin of IFN-gammaR(-/-) or IL-17R(-/-) recipients compared with WT controls. Interestingly, injection of rIL-17 in the skin induces inflammation with a high level of leukocyte infiltration whereas injection of IFN-gamma induces inflammation with a high level of reactive oxidative species. Moreover, neutralization of IL-17 in IFN-gammaR(-/-) or IFN-gamma in IL-17R(-/-) mice further suppresses the adoptive transfer of CHS by hapten-primed WT CD8(+) T cells. The study demonstrates that IFN-gamma and IL-17 mediate the elicitation of CHS by different mechanisms and that both cytokines are required for optimal responses. This outcome improves understanding of pathogenesis and provides new insights into therapeutic strategies for CHS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553527      PMCID: PMC3179907          DOI: 10.4049/jimmunol.0804108

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

1.  Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis.

Authors:  Erik Lubberts; Paul Schwarzenberger; Weitao Huang; Jill R Schurr; Jacques J Peschon; Wim B van den Berg; Jay K Kolls
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  CD8+ IL-17-producing T cells are important in effector functions for the elicitation of contact hypersensitivity responses.

Authors:  Donggou He; Lizhi Wu; Hee Kyung Kim; Hui Li; Craig A Elmets; Hui Xu
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

Review 3.  Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.

Authors:  S L Constant; K Bottomly
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

4.  Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis.

Authors:  Hitoshi Akiba; Jeanne Kehren; Marie-Thérèse Ducluzeau; Maya Krasteva; Françoise Horand; Dominique Kaiserlian; Fumio Kaneko; Jean-François Nicolas
Journal:  J Immunol       Date:  2002-03-15       Impact factor: 5.422

Review 5.  Interferons, immunity and cancer immunoediting.

Authors:  Gavin P Dunn; Catherine M Koebel; Robert D Schreiber
Journal:  Nat Rev Immunol       Date:  2006-11       Impact factor: 53.106

6.  Defective immune response and severe skin damage following UVB irradiation in interleukin-6-deficient mice.

Authors:  N Nishimura; C Tohyama; M Satoh; H Nishimura; V E Reeve
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 7.  The role of NO in contact hypersensitivity.

Authors:  R Ross; A B Reske-Kunz
Journal:  Int Immunopharmacol       Date:  2001-08       Impact factor: 4.932

8.  IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.

Authors:  C Albanesi; A Cavani; G Girolomoni
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

9.  Role of interferon-gamma in contact hypersensitivity assessed in interferon-gamma receptor-deficient mice.

Authors:  M Saulnier; S Huang; M Aguet; B Ryffel
Journal:  Toxicology       Date:  1995-09-18       Impact factor: 4.221

10.  Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Authors:  P Ye; F H Rodriguez; S Kanaly; K L Stocking; J Schurr; P Schwarzenberger; P Oliver; W Huang; P Zhang; J Zhang; J E Shellito; G J Bagby; S Nelson; K Charrier; J J Peschon; J K Kolls
Journal:  J Exp Med       Date:  2001-08-20       Impact factor: 14.307

View more
  45 in total

Review 1.  [Immunology of contact allergy].

Authors:  S F Martin
Journal:  Hautarzt       Date:  2011-10       Impact factor: 0.751

2.  In Vivo Suppression of Heat Shock Protein (HSP)27 and HSP70 Accelerates DMBA-Induced Skin Carcinogenesis by Inducing Antigenic Unresponsiveness to the Initiating Carcinogenic Chemical.

Authors:  Nabiha Yusuf; Tahseen H Nasti; Israr Ahmad; Sanim Chowdhury; Hasan Mohiuddin; Hui Xu; Mohammad Athar; Laura Timares; Craig A Elmets
Journal:  J Immunol       Date:  2015-04-03       Impact factor: 5.422

3.  Natural killer cell-mediated contact sensitivity develops rapidly and depends on interferon-α, interferon-γ and interleukin-12.

Authors:  Monika Majewska-Szczepanik; Silke Paust; Ulrich H von Andrian; Philip W Askenase; Marian Szczepanik
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

4.  Interleukin-17 mediated inflammatory responses are required for ultraviolet radiation-induced immune suppression.

Authors:  Hui Li; Ram Prasad; Santosh K Katiyar; Nabiha Yusuf; Craig A Elmets; Hui Xu
Journal:  Photochem Photobiol       Date:  2014-10-13       Impact factor: 3.421

5.  Epidermal phospholipase Cδ1 regulates granulocyte counts and systemic interleukin-17 levels in mice.

Authors:  Kaori Kanemaru; Yoshikazu Nakamura; Kojiro Sato; Ryota Kojima; Saori Takahashi; Mami Yamaguchi; Manabu Ichinohe; Hiroshi Kiyonari; Go Shioi; Kenji Kabashima; Kyoko Nakahigashi; Masataka Asagiri; Colin Jamora; Hideki Yamaguchi; Kiyoko Fukami
Journal:  Nat Commun       Date:  2012-07-17       Impact factor: 14.919

Review 6.  Inflammatory and immune mechanisms in contact hypersensitivity (CHS) in rats.

Authors:  A Popov; I Mirkov; M Kataranovski
Journal:  Immunol Res       Date:  2012-04       Impact factor: 2.829

7.  Eosinophil-dependent skin innervation and itching following contact toxicant exposure in mice.

Authors:  James J Lee; Cheryl A Protheroe; Huijun Luo; Sergei I Ochkur; Gregory D Scott; Katie R Zellner; Randall J Raish; Mark V Dahl; Miriam L Vega; Olivia Conley; Rachel M Condjella; Jake A Kloeber; Joseph L Neely; Yash S Patel; Patty Maizer; Andrew Mazzolini; Allison D Fryer; Noah W Jacoby; David B Jacoby; Nancy A Lee
Journal:  J Allergy Clin Immunol       Date:  2014-08-13       Impact factor: 10.793

8.  Paeoniflorin inhibits inflammatory responses in mice with allergic contact dermatitis by regulating the balance between inflammatory and anti-inflammatory cytokines.

Authors:  Chun Wang; Jun Yuan; Hua-Xun Wu; Yan Chang; Qing-Tong Wang; Yu-Jing Wu; Li-Hua Liu; Wei Wei
Journal:  Inflamm Res       Date:  2013-10-05       Impact factor: 4.575

Review 9.  Natural killer cells: walking three paths down memory lane.

Authors:  Gundula Min-Oo; Yosuke Kamimura; Deborah W Hendricks; Tsukasa Nabekura; Lewis L Lanier
Journal:  Trends Immunol       Date:  2013-03-14       Impact factor: 16.687

10.  1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses.

Authors:  Shelley Gorman; Melinda A Judge; Jennifer T Burchell; Debra J Turner; Prue H Hart
Journal:  Immunology       Date:  2010-01-06       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.